Profile data is unavailable for this security.
About the company
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma and the SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is a wearable eyelid technology that delivers targeted and adjustable heat to the meibomian glands of the eyelids in adult patients with evaporative dry eye disease due to meibomian gland disfunction.
- Revenue in USD (TTM)81.50m
- Net income in USD-54.75m
- Incorporated2010
- Employees214.00
- LocationSight Sciences Inc4040 Campbell Ave,, Suite 100MENLO PARK 94025United StatesUSA
- Phone+1 (415) 889-0550
- Fax+1 (302) 655-5049
- Websitehttps://www.sightsciences.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Senseonics Holdings Inc | 23.30m | -80.59m | 222.97m | 132.00 | -- | 11.76 | -- | 9.57 | -0.1354 | -0.1354 | 0.039 | 0.1067 | 0.1635 | 2.51 | 6.51 | 176,515.20 | -56.55 | -73.65 | -66.90 | -106.97 | 12.93 | -40.41 | -345.89 | -649.86 | 3.70 | -11.13 | 0.4783 | -- | 36.62 | 3.43 | -142.49 | -- | -18.76 | -- |
| Utah Medical Products, Inc. | 49.04m | 16.38m | 241.41m | 169.00 | 15.18 | 1.92 | 11.17 | 4.92 | 4.51 | 4.51 | 13.50 | 35.60 | 0.3727 | 2.09 | 13.24 | 290,201.20 | 12.44 | 12.69 | 13.02 | 13.19 | 59.05 | 61.57 | 33.39 | 30.51 | 17.89 | -- | 0.00 | 37.05 | -3.93 | 3.64 | 0.9834 | 1.65 | 9.71 | 1.86 |
| AngioDynamics, Inc. | 324.01m | -192.37m | 256.35m | 815.00 | -- | 1.18 | -- | 0.7912 | -4.78 | -4.78 | 8.10 | 5.41 | 0.7468 | 2.66 | 6.46 | 397,555.80 | -44.34 | -9.12 | -54.02 | -10.17 | 50.17 | 54.23 | -59.37 | -19.48 | 1.62 | -- | 0.00 | -- | 7.13 | 5.30 | -97.54 | -- | 3.55 | -- |
| Pulmonx Corp | 72.99m | -58.73m | 270.55m | 279.00 | -- | 2.45 | -- | 3.71 | -1.54 | -1.54 | 1.91 | 2.85 | 0.399 | 1.14 | 7.81 | 261,627.20 | -32.11 | -26.27 | -35.87 | -28.97 | 74.31 | 71.95 | -80.46 | -93.76 | 6.14 | -- | 0.252 | -- | 27.98 | 27.98 | -3.26 | -- | 20.62 | -- |
| Orchestra Biomed Holdings Inc | 2.22m | -51.64m | 282.73m | 56.00 | -- | 4.94 | -- | 127.59 | -1.47 | -1.47 | 0.063 | 1.60 | 0.0203 | 1.01 | 30.99 | 39,571.43 | -47.18 | -- | -52.58 | -- | 92.06 | -- | -2,330.46 | -- | 7.33 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
| Tactile Systems Technology Inc | 276.67m | 28.19m | 290.85m | 992.00 | 10.35 | 1.50 | 8.37 | 1.05 | 1.18 | 1.18 | 11.70 | 8.14 | 1.01 | 6.77 | 6.05 | 278,896.20 | 10.30 | 0.9015 | 12.18 | 1.09 | 49.98 | 49.10 | 10.19 | 0.8309 | 3.63 | -- | 0.128 | 0.00 | 11.20 | 13.81 | 259.60 | 33.91 | -23.62 | -- |
| Zynex Inc | 188.68m | 8.17m | 297.10m | 1.10k | 41.35 | 9.15 | 23.49 | 1.57 | 0.2261 | 0.2261 | 5.39 | 1.02 | 1.59 | 2.52 | 6.56 | 171,530.00 | 6.89 | 14.58 | 8.41 | 17.52 | 80.22 | 79.62 | 4.33 | 10.44 | 2.87 | 7.24 | 0.6381 | -- | 16.54 | 42.01 | -42.91 | 0.3741 | 2.19 | -- |
| AxoGen Inc | 163.73m | -21.28m | 299.81m | 426.00 | -- | 3.22 | -- | 1.83 | -0.4943 | -0.4943 | 3.80 | 2.13 | 0.8709 | 1.49 | 7.04 | 384,333.30 | -11.32 | -13.92 | -12.82 | -15.84 | 78.34 | 79.74 | -13.00 | -20.28 | 2.23 | -8.76 | 0.3346 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
| Treace Medical Concepts Inc | 196.03m | -54.75m | 336.70m | 516.00 | -- | 2.66 | -- | 1.72 | -0.8885 | -0.8885 | 3.18 | 2.04 | 0.797 | 1.28 | 7.07 | 379,905.00 | -22.26 | -- | -25.98 | -- | 80.99 | -- | -27.93 | -- | 3.22 | -- | 0.2958 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| Nevro Corp | 430.75m | -82.59m | 339.74m | 1.22k | -- | 1.22 | -- | 0.7887 | -2.28 | -2.28 | 11.90 | 7.59 | 0.736 | 1.14 | 6.04 | 354,523.50 | -14.11 | -13.64 | -16.06 | -16.68 | 68.94 | 68.54 | -19.17 | -20.67 | 5.57 | -- | 0.4354 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
| Sight Sciences Inc | 81.50m | -54.75m | 351.78m | 214.00 | -- | 3.21 | -- | 4.32 | -1.12 | -1.12 | 1.67 | 2.20 | 0.4628 | 1.66 | 5.09 | 380,822.40 | -31.09 | -38.78 | -33.65 | -42.20 | 85.73 | 80.74 | -67.18 | -105.14 | 12.42 | -14.76 | 0.2358 | -- | 13.63 | 60.84 | 35.59 | -- | 6.77 | -- |
| Jin Medical International Ltd | 19.82m | 2.88m | 417.98m | 245.00 | 134.64 | 17.36 | 134.65 | 21.09 | 0.0198 | 0.0198 | 0.1414 | 0.1538 | 0.7363 | 2.21 | 4.77 | 80,903.92 | 10.69 | 12.81 | 14.68 | 20.92 | 34.23 | 33.58 | 14.52 | 14.60 | 2.92 | -- | 0.1464 | 0.00 | 3.29 | -1.07 | 6.34 | -4.80 | -9.50 | -- |
| ZimVie Inc | 455.22m | -51.16m | 433.34m | 2.60k | -- | 1.12 | -- | 0.9519 | -1.92 | -14.01 | 17.11 | 14.24 | 0.3299 | 1.09 | 3.73 | 175,085.40 | -3.71 | -- | -4.28 | -- | 63.05 | 65.51 | -11.24 | -8.73 | 2.23 | -0.343 | 0.5673 | -- | -1.26 | -16.08 | -19.50 | -- | -23.70 | -- |
| Nano-X Imaging Ltd | 10.01m | -61.26m | 458.84m | 164.00 | -- | 2.48 | -- | 45.83 | -1.08 | -1.08 | 0.1755 | 3.20 | 0.045 | -- | 7.28 | 61,042.68 | -27.54 | -30.98 | -30.10 | -35.10 | -71.15 | -- | -611.89 | -1,527.24 | 5.59 | -- | 0.0177 | -- | 15.47 | -- | 46.33 | -- | 114.35 | -- |
| MaxCyte Inc | 44.05m | -36.57m | 466.27m | 143.00 | -- | 2.06 | -- | 10.58 | -0.3532 | -0.3532 | 0.4253 | 2.17 | 0.1633 | 0.463 | 5.77 | 308,067.80 | -13.56 | -13.18 | -14.36 | -14.33 | 88.32 | 88.79 | -83.01 | -62.96 | 12.37 | -- | 0.00 | -- | -6.72 | 19.89 | -60.89 | -- | 39.13 | -- |
| Pacific Biosciences of California Inc | 200.43m | -296.90m | 490.24m | 796.00 | -- | 0.7552 | -- | 2.45 | -1.14 | -1.14 | 0.7695 | 2.38 | 0.1124 | 2.21 | 6.69 | 251,797.70 | -16.65 | -16.19 | -18.40 | -17.81 | 28.81 | 37.35 | -148.13 | -136.21 | 8.36 | -21.84 | 0.5791 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
Data as of Jun 07 2024. Currency figures normalised to Sight Sciences Inc's reporting currency: US Dollar USD
26.26%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BofA Securities, Inc.as of 31 Mar 2024 | 3.00m | 6.06% |
| UBS Securities LLCas of 31 Mar 2024 | 2.87m | 5.80% |
| Jackson Square Partners LLCas of 31 Mar 2024 | 1.61m | 3.25% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 1.51m | 3.05% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 1.33m | 2.68% |
| JPMorgan Investment Management, Inc.as of 31 Mar 2024 | 902.73k | 1.82% |
| Geode Capital Management LLCas of 31 Mar 2024 | 581.37k | 1.17% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 445.14k | 0.90% |
| Jacobs Levy Equity Management, Inc.as of 31 Mar 2024 | 377.06k | 0.76% |
| D. E. Shaw & Co. LPas of 31 Mar 2024 | 374.41k | 0.76% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
